kdigo guideline (2024): evaluation and management of chronic kidney disease MCQ (SBA): CKD G3b A3

Instant feedback + full explanation. One question, done properly.

Mediumeven without diabetes. DPP‑4 inhibitors (B)CKD G3b A3kdigo guideline (2024): evaluation and management of chronic kidney disease

A 63-year-old with CKD G3b A3 (eGFR 38 mg/g) without diabetes. BP is controlled on ACE inhibitor. Which additional agent is recommended to slow CKD progression?

Educational content. Not a substitute for clinical judgement or local policy.

kdigo guideline (2024): evaluation and management of chronic kidney di